← The Wire
TRVINasdaq
Trevi Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1563880
Develops and commercializes Haduvio for chronic cough in adults with lung diseases
$2.02B
Market cap
$18.63
Last close
+2.6%
1D
+5.2%
5D
2.9M
Volume
Price · last 39 sessions+29.6%
May 4L $13.24 · H $18.63Jun 29
152
Total filings
Jun 4, 2026
Last filing
12/31
Fiscal year end
10-Q10-QMay 5, 202610-Q10-QNov 13, 202510-Q10-QAug 7, 202510-Q10-QMay 8, 202510-Q10-QNov 6, 202410-Q10-QAug 8, 202410-Q10-QMay 7, 202410-Q10-QNov 9, 202310-Q10-QAug 10, 202310-Q10-QMay 11, 202310-Q10-QNov 10, 202210-Q10-QAug 11, 202210-Q10-QMay 12, 202210-Q10-QNov 10, 202110-Q10-QAug 12, 202110-Q10-QMay 13, 202110-Q10-QNov 12, 202010-Q10-QAug 13, 202010-Q10-QMay 7, 202010-Q10-QNov 14, 201910-Q10-QAug 12, 201910-Q10-QJun 14, 2019
Similar companies
Comparable business profile · signals at a glance